Amvis Holdings (MEX:7071N) Research & Development: MXN0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:7071N Amvis Holdings Inc MEX:7071N
78 GF Score
Price MXN111.01
GF Value MXN346.21
! 5 Warning Signs
View Full Analysis

What is Amvis Holdings Research & Development?

Amvis Holdings MEX:7071N 78 Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:7071N with a GF Score™ of 78/100 and a GF Value™ of MXN346.21. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Amvis Holdings's Research & Development for the three months ended in Mar. 2026 was MXN0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was MXN0 Mil.

Amvis Holdings  (MEX:7071N) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Amvis Holdings Research & Development Related Terms

Amvis Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Amvis Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amvis Holdings Research & Development Chart

Amvis Holdings Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amvis Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:7071N
78GF Score
Amvis Holdings Inc MEX:7071N
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amvis Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MXN0 Mil mean?
Amvis Holdings (MEX:7071N) has a Research & Development of MXN0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Amvis Holdings and its competitors.
Is Amvis Holdings' Research & Development too high?
Amvis Holdings' current Research & Development is MXN0 Mil. Overall, Amvis Holdings has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does Amvis Holdings' Research & Development compare to HCA and THC?
Amvis Holdings' Research & Development of MXN0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Amvis Holdings and its competitors. Amvis Holdings's current Research & Development is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amvis Holdings stock overvalued right now?
Amvis Holdings (MEX:7071N) has a current Research & Development of MXN0 Mil. The stock's GF Value™ is MXN346.21, compared to a current price of MXN111.01 — trading 67.9% below its estimated fair value. The current Research & Development is MXN0 Mil. Amvis Holdings' overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Amvis Holdings (MEX:7071N), the current Research & Development is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amvis Holdings (MEX:7071N) Overvalued in 2026?

Based on GuruFocus' analysis, Amvis Holdings stock appears to be undervalued. The current stock price of MXN111.01 is trading 67.9% below its estimated GF Value™ of MXN346.21.

Key valuation signals for MEX:7071N:

  • Research & Development: MXN0 Mil
  • GF Value™: MXN346.21 vs. price of MXN111.01 (67.9% below fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the MEX:7071N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amvis Holdings Business Description

Other Exchanges 7071:Japan
Address 1-6-1 Kyobashi, Chuo-ku, Tokyo, JPN, 103-0028
Amvis Holdings Inc operates as a holding company. The company, through its subsidiaries, is engaged in home nursing care, home care support, consulting, and operational support related to the management and operation of residential nursing homes and medical facilities. The company is also engaged in the business of renting land and buildings to be used for residential, paid nursing homes, and medical centers.
78GF Score

Get the complete analysis for MEX:7071N

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN111.01
Price
MXN346.21
GF Value